Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-25-025292
Filing Date
2025-03-20
Accepted
2025-03-20 07:50:56
Documents
84
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0234504-20f_inflarxnv.htm   iXBRL 20-F 2537349
2 LIST OF SUBSIDIARIES ea023450401ex8-1_inflarxnv.htm EX-8.1 1552
3 INSIDER TRADING POLICY ea023450401ex11-1_inflarxnv.htm EX-11.1 76574
4 CERTIFICATION ea023450401ex12-1_inflarxnv.htm EX-12.1 8917
5 CERTIFICATION ea023450401ex12-2_inflarxnv.htm EX-12.2 8966
6 CERTIFICATION ea023450401ex13-1_inflarxnv.htm EX-13.1 3386
7 CERTIFICATION ea023450401ex13-2_inflarxnv.htm EX-13.2 3386
8 CONSENT OF EY GMBH & CO. KG WIRTSCHAFTSPRUFUNGSGESELLSCHAFT ea023450401ex15-1_inflarxnv.htm EX-15.1 3855
9 CLAWBACK POLICY ea023450401ex97-1_inflarxnv.htm EX-97.1 28691
10 GRAPHIC image_001.jpg GRAPHIC 87833
11 GRAPHIC image_002.jpg GRAPHIC 56320
12 GRAPHIC image_003.jpg GRAPHIC 45042
13 GRAPHIC image_004.jpg GRAPHIC 60659
14 GRAPHIC image_005.jpg GRAPHIC 87432
  Complete submission text file 0001213900-25-025292.txt   10265065

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE ifrx-20241231.xsd EX-101.SCH 98624
16 XBRL CALCULATION FILE ifrx-20241231_cal.xml EX-101.CAL 47227
17 XBRL DEFINITION FILE ifrx-20241231_def.xml EX-101.DEF 358275
18 XBRL LABEL FILE ifrx-20241231_lab.xml EX-101.LAB 650715
19 XBRL PRESENTATION FILE ifrx-20241231_pre.xml EX-101.PRE 375736
87 EXTRACTED XBRL INSTANCE DOCUMENT ea0234504-20f_inflarxnv_htm.xml XML 1333354
Mailing Address WINZERLAER STR. 2 JENA 2M 07745
Business Address WINZERLAER STR. 2 JENA 2M 07745 49 3641 508180
InflaRx N.V. (Filer) CIK: 0001708688 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38283 | Film No.: 25754535
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)